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Lipid-mediated Wnt protein stabilization enables
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Wnt signalling proteins are essential for culture of human organ stem cells in organoids, but
most Wnt protein formulations are poorly active in serum-free media. Here we show that
puriﬁed Wnt3a protein is ineffective because it rapidly loses activity in culture media due to
its hydrophobic nature, and its solubilization requires a detergent, CHAPS (3-[(3-cholami-
dopropyl) dimethylammonio]-1-propanesulfonate), that interferes with stem cell
self-renewal. By stabilizing the Wnt3a protein using phospholipids and cholesterol as carriers,
we address both problems: Wnt activity remains stable in serum-free media, while non-toxic
carriers allow the use of high Wnt concentrations. Stabilized Wnt3a supports strongly
increased self-renewal of organ and embryonic stem cells and the serum-free establishment
of human organoids from healthy and diseased intestine and liver. Moreover, the lipophilicity
of Wnt3a protein greatly facilitates its puriﬁcation. Our ﬁndings remove a major obstacle
impeding clinical applications of adult stem cells and offer advantages for all cell culture uses
of Wnt3a protein.
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T
he recent establishment of organoid cultures from intes-
tine, pancreas, liver and other human organs holds great
promise for disease modelling, drug development, perso-
nalized medicine, and gene and stem cell therapies1–5. Organoids
reproduce many organ properties, including disease symptoms
and their response to therapeutics6,7. This allows the screening of
drugs to select optimal treatments for, for example, cystic ﬁbrosis6
or colon cancer patients7, bringing true personalized medicine to
the patient. Self-renewal of the stem cells in the organoids
requires activation of the Wnt pathway. In mouse organoids this
is achieved by ampliﬁcation of endogenous Wnt signals by the
Wnt potentiator R-Spondin1 (ref. 1). In contrast, human
organoids require additional Wnt ligands, provided by a serum-
containing medium conditioned by a Wnt3a-producing cell line3.
The conditioned medium contains undeﬁned, differentiation-
inducing components undesirable for diagnostic assays or other
clinical applications. Moreover, screening of serum batches is
necessary, and select sera support only some types of organoid,
complicating culture. For diagnostic and therapeutic application,
replacement of Wnt3a-conditioned media by puriﬁed factors
would therefore be strongly preferred.
Wnt proteins are soluble signalling molecules that require
attachment of a palmitoylate moiety to gain activity, and for this
reason they are hydrophobic8–10. To maintain solubility, Wnt
proteins are puriﬁed and stored in the presence of the detergent
CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-1-propane-
sulfonate)8. However, on dilution in cell culture media, the
detergent concentration drops below the level required to
maintain Wnt solubility. This leads to rapid aggregation and
loss of activity of the protein, in particular in the absence of
serum11. Several studies have shown that Wnt proteins have
a high afﬁnity for phospholipid vesicles, likely due to their
hydrophobicity12,13, and it was recently shown that this
association prolongs the activity of Wnt3a protein in the
absence of serum13.
In the current study, we found that puriﬁed Wnt3a protein
performed poorly in the establishment and propagation of human
organ stem cell cultures in serum-free conditions. We identiﬁed
two factors responsible for this poor performance. First,
insufﬁcient Wnt activity is maintained due to the rapid loss of
activity in serum-free medium. Second, the presence of CHAPS in
the puriﬁed Wnt3a suppresses stem cell self-renewal. We
demonstrate here that association of the hydrophobic Wnt3a
protein with soluble lipid carriers, including liposomes and
hydrophobic nanoparticles (NPs), enhances its stability such that
it now supports organ stem cells in the absence of serum and
CHAPS. Moreover, we show that the afﬁnity of Wnt3a to lipids
has applications in the puriﬁcation of recombinant Wnt3a. Our
ﬁndings constitute an important step towards the use of human
organ stem cells in clinical scenarios.
Results
Puriﬁed Wnt3a protein adversely affects stem cell cultures.
Adult human duodenum organoids were derived from intestinal
biopsies as described3. However, while organoids were success-
fully derived using Wnt3a conditioned medium, we found
that puriﬁed Wnt3a protein failed to support the derivation
of duodenum organoids (Fig. 1a). Active Wnt proteins are
palmitoylated8–10 and require the detergent CHAPS to maintain
solubility on puriﬁcation8. On dilution in cell culture medium,
the CHAPS concentration drops below the level required to
maintain Wnt activity, and the protein rapidly loses activity11.
To investigate whether activity loss of Wnt3a protein in serum-
free medium caused its poor performance, we used the
clonal expansion of mouse embryonic stem cells (ESCs) as a
Wnt-sensitive stem cell assay14. Puriﬁed Wnt3a protein suppor-
ted ESC self-renewal when added at every passage (3 days)
(Fig. 1b), but daily addition was required when endogenous Wnt
proteins were eliminated using the small-molecule inhibitor
IWP2 (Fig. 1b), showing that puriﬁed Wnt3a protein provides
only a short-lived stimulus. To determine its stability, we
incubated Wnt3a protein for various periods of time in the
culture medium at 37 C and assayed the remaining activity using
a luciferase reporter assay. While Wnt3a-conditioned medium
retained activity over several days, puriﬁed Wnt3a lost its activity
within a few hours (Fig. 1c). Surprisingly, when we doubled the
concentration of Wnt3a to compensate for this rapid loss of
activity, ESC self-renewal was repressed (Fig. 1d). This appeared
due to a cytotoxic effect of the detergent CHAPS because
doubling its concentration while maintaining the same level of
Wnt3a repressed self-renewal to a similar extent (Fig. 1d). While
CHAPS concentrations above 0.25% kill cells by lysing their
membranes13, CHAPS stayed below 0.02% in our experiments.
This shows that low CHAPS concentrations that are readily
accumulated during normal cell culture interfere with stem cell
self-renewal. Thus, the use of puriﬁed Wnt3a protein suffers from
dual impediments: it rapidly loses activity on addition to serum-
free cell cultures, and the cytotoxicity of the detergent CHAPS
prevents a compensating increase in Wnt3a concentration.
Lipids enhance Wnt3a protein stability. We and others pre-
viously observed that Wnt proteins associate with lipid vesicles,
and that this prolongs their activity12,13. We explored whether
liposomes would support Wnt3a solubility in the absence of
CHAPS, and improve its ability to support stem cells. Liposomes
were composed of the phospholipid DMPC (1,2-dimyristoyl-
sn-glycero-3-phosphocholine), required to maintain Wnt3a
activity12. Since DMPC liposomes rapidly aggregated and
precipitated, we added the charged phospholipid DMPG
(1,2-dimyristoyl-sn-glycero-3-phospho-rac-glycerol) to prevent
aggregation. We further tested whether inclusion of cholesterol
would enhance the physical stability of liposomes15. The
liposomes were relatively uniformly sized, with diameters
ranging from 130–150 nm and low polydispersity indices
(Supplementary Table 1). On addition of Wnt3a protein to the
liposomes, CHAPS was removed by dialysis (Supplementary
Fig. 1a) with little effect on size distribution (Supplementary
Table 1). About 85% of the Wnt3a protein associated with the
liposomes (Supplementary Fig. 1b), in agreement with earlier
measurements12. A dose–response assay showed that association
with liposomes did not affect the speciﬁc activity of Wnt3a
(Supplementary Fig. 1c). Importantly, the liposomes slowed the
loss of Wnt3a activity over time, in particular at high levels of
cholesterol (Fig. 2a), regardless of the removal of CHAPS
(Fig. 2b). This holds promise for their use in serum-free stem
cell cultures, and dialysed DMPC, DMPG and cholesterol
(10:1:10 molar ratio) liposomes were therefore used in the
remainder of this study.
Lipid-stabilized Wnt3a supports serum-free stem cell culture.
Wnt3a liposomes maintained the activity of the Wnt reporter
7xTcf-eGFP16 for more than 3 days, while the activity started to
decline 2 days after the addition of puriﬁed Wnt3a (Fig. 2c).
Moreover, Wnt3a liposomes promoted a more than 10-fold
higher expansion of undifferentiated ESCs (Fig. 2d), and higher
proliferation of human duodenum organoid cells than puriﬁed
Wnt3a (Fig. 2e). To speciﬁcally assay for the expansion of organ
stem cells, we passaged the organoids twice at clonal density on
dissociation into single cells and quantiﬁed the number of new
organoids. While puriﬁed Wnt3a performed poorly in this assay,
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Wnt3a liposomes efﬁciently supported organoid formation from
single cells in a dose-dependent manner (Fig. 3a). Raising
the concentration of puriﬁed Wnt3a ultimately suppressed self-
renewal (Fig. 3a), suggesting that here too CHAPS inhibited self-
renewal. Indeed, Wnt3a liposomes, lacking CHAPS, strongly
promoted stem cell expansion at concentrations over 1 mgml 1
Wnt3a (Fig. 3a). Moreover, and in contrast to regular puriﬁed
Wnt3a, Wnt3a liposomes supported efﬁcient de novo derivation
and long-term maintenance of duodenum organoids in serum-
free medium (Figs 1a and 3b). The newly derived duodenum
organoids displayed robust long-term expansion and could be
maintained in Wnt3a liposomes for more than 6 months at
passaging ratios of 1:6–1:8 every 7–10 days. These data show that
dialysed Wnt3a liposomes promoted stem cell self-renewal by
eliminating the cytotoxic CHAPS from the cultures while
prolonging Wnt activity.
We veriﬁed that the newly derived duodenum organoids
expressed stem cell, proliferation and differentiation markers as
found in the intestinal crypt, and that their expression was com-
parable with organoids derived in the presence of Wnt3a condi-
tioned medium. The intestinal stem cell markers LGR5 (ref. 17)
and TROY18 were expressed at similar level as in organoids
derived in the Wnt3a conditioned medium (Fig. 3c), suggesting
that Wnt3a liposomes and the conditioned medium maintained
similar proportions of stem cells in the organoids. The tyrosine
kinase receptor EPHB2 is highly expressed in intestinal crypts1,19
(Fig. 3d, arrows) and immunostaining revealed high expression
throughout the organoids (Fig. 3d). Likewise, expression of the
proliferation marker Ki67 was found in the crypts and throu-
ghout the organoids (Fig. 3d, arrows). Differentiation markers for
enterocytes (alkaline phosphatase), goblet cells (periodic acid-
Schiff staining) and endocrine cells (chromogranin A) were
absent from both the crypts and the organoids, while clearly
detectable in the differentiated intestinal epithelium (Fig. 3d,
arrows). These data show that organoids derived in the presence
of Wnt3a liposomes display characteristics of the proliferative
stem cell compartment of the intestinal crypt. Moreover, we
veriﬁed the multilineage potential of the organoids by inducing
their differentiation towards enterocytes, goblet cells and
enteroendocrine cells. On removal of liposomal Wnt3a, cells
carrying the enterocyte marker Villin appeared within 5 days
(Fig. 3e). Differentiation towards goblet and enteroendocrine cells
was induced by the removal of SB202190 and nicotinamide3.
Expression of the goblet marker Mucin2 and the enteroendocrine
marker chromogranin A was visible within 5 days of induction
(Fig. 3e). Moreover, in line with previous ﬁndings3, the Paneth
cell marker lysozyme was present both in expansion and
differentiation conditions, indicating the presence of Paneth
cells in the organoids (Fig. 3e). Together, these data show that the
organoids derived in Wnt3a liposomes contained multipotent
stem cells and were similar to those derived in Wnt3a-
conditioned medium with regard to cell types present and
similarity to the intestinal crypt.
Palmitoylated proteins reversibly interact with lipid bilayers20,
which may underlie the interaction of Wnt3a with liposomes. We
tested whether the prior association of Wnt protein with
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Figure 1 | Instability and detergent-associated toxicity of Wnt3a protein adversely affect stem cell cultures. (a) Human duodenum organoids derived in
the presence of Wnt3a-conditioned medium, or puriﬁed Wnt3a protein (400ngml 1) in serum-free medium. (b) Expansion of ESCs able to form
undifferentiated, alkaline phosphatase-positive (APþ ) colonies at clonal density. Wnt3a and medium are refreshed daily or after every passage (3 days)
(n¼ 3, mean±s.e.m.). (c) Wnt activity retained after incubation for the indicated amounts of time at 37 C. Wnt3a (250 ngml 1) was diluted in serum-
free medium (n¼ 3, mean±s.e.m.). (d) Expansion of ESCs able to form APþ colonies. Wnt3a and media are refreshed daily (n¼ 3, mean±s.e.m.). Scale
bar, 100 mm. P, passage.
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liposomes was required for the stabilizing effect in cell culture.
However, separate addition of liposomes also prolonged the
activity of Wnt3a in a lipid-concentration-dependent manner
(Fig. 4a). Moreover, separate addition of liposomes and puriﬁed
Wnt3a supported the clonal expansion of duodenum stem cells
(Fig. 4b). This shows that simple addition of liposomes to
organoid medium enhances the stability of Wnt3a protein and
allows the serum-free expansion of human organoids. We
explored alternatives for liposomes such as hydrophobic NPs
that can be more easily stored and shipped. Poly(D, L-lactide-co-
glycolide) (PLGA) is an FDA-approved biodegradable copolymer
with excellent biocompatibility properties and long shelf-life21.
We coated PLGA NPs with DMPC, stored them for 1 year at 4 C
to test the shelf-life and incubated them with Wnt3a protein,
followed by dialysis to remove CHAPS. The NPs stabilized Wnt3a
activity to a similar degree as liposomes (Fig. 4c). Moreover,
separate addition of Wnt3a protein and DMPC-coated NPs also
prolonged Wnt activity (Fig. 4c). Thus, Wnt3a activity in serum-
free cell cultures can easily be prolonged by the addition of PLGA
NPs. However, the presence of CHAPS limits the concentration
of Wnt3a that can be used via this approach. To obtain a CHAPS-
free stabilized Wnt3a reagent with long shelf-life, we lyophilized
dialysed Wnt3a liposomes. On reconstitution, lyophilized Wnt3a
liposomes retained most of their activity and physical properties
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Figure 2 | Lipid-stabilized Wnt3a protein shows enhanced target gene activation and embryonic stem cell expansion in serum-free culture.
(a) Quantiﬁcation of Wnt activity retained after incubation of the indicated liposomes (containing 250ngml 1 Wnt3a ﬁnal concentration) in serum-free
medium for the indicated amounts of time at 37 C (n¼ 3, mean±s.e.m.). (b) Wnt activity retained after incubation of DMPC/DMPG/Chol 10:1:10
liposomes in serum-free medium for the indicated amounts of time at 37 C (n¼ 3, mean±s.e.m.). (c) ESCs carrying the Wnt reporter 7xTcf-eGFP were
imaged for GFP 3 days after the addition of puriﬁed or liposomal Wnt3a (250 ngml 1) in serum-free medium (upper panels) and analysed by ﬂow
cytometry over 4 days (lower panels). (d) Quantiﬁcation of expansion of R1 ESCs able to form alkaline phosphate-positive (APþ ) colonies at clonal density
in serum-free medium. Indicated reagents are added after every passage (3 days) (n¼ 3, mean±s.e.m.). (e) Expansion of human duodenum organoids
cultured with the indicated reagents, determined by ATP assay (n¼ 3, mean±s.e.m.). Scale bars, (c) 100mm.
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(Fig. 4d and Supplementary Table 2), thereby providing Wnt3a
protein in a stabilized CHAPS-free storable format that is
generally applicable and supports the serum-free derivation and
maintenance of human organoid cultures. Thus, we developed
several formats for enhancing Wnt3a stability in serum-free cell
culture, depending on the sensitivity of the cell culture system to
CHAPS and the ﬁnal Wnt3a concentration required.
Since recombinant Wnt proteins are puriﬁed from conditioned
media, they contain serum-derived contaminants. While low
levels of these contaminants are compatible with clinical
applications, as long as such sera are veriﬁed free from known
infectious disease markers (for example, bovine sera sourced from
certiﬁed transmissible spongiform encephalopathy/bovine spon-
giform encephalopathy-free herds), they may affect stem cell
cultures. We found that highly puriﬁed Wnt3a, of more than 90%
purity, demonstrated much lower stability than less pure
preparations (Fig. 5a,b). While this suggests that some conta-
minants enhance Wnt protein stability, the high-purity Wnt3a
was nonetheless successfully stabilized by liposomes (Fig. 5b) and
supported the clonal expansion of human duodenum stem cells
(Fig. 5c). The development of serum-free stabilizers to produce
Wnt proteins or of alternative molecules that activate the Wnt
pathway are potential avenues towards completely eliminating
sera. Recently, it was shown that the serum glycoprotein afamin
forms a complex with Wnt3a that remains soluble in aqueous
buffer22. However, we found that recombinant afamin was unable
to prolong the activity of puriﬁed Wnt3a when present at
concentrations found in serum-containing media23 (Supple-
mentary Fig. 3). Possibly, recombinant afamin lacks essential
modiﬁcations or its stabilization of Wnt3a only occurs when the
molecules are complexed during their biosynthesis. Glycogen
synthase kinase 3 inhibitors such as CHIR99021 support strong
b-catenin stabilization and are far cheaper, more stable and easier
to use than Wnt ligands24. However, glycogen synthase kinase 3
inhibitors cannot always substitute for Wnt ligands in the
maintenance of stem cells25, and we were unable to propagate
human duodenum organoids using CHIR99021 in lieu of puriﬁed
Wnt3a (Supplementary Fig. 4). Since purifying Wnt3a to very
high purity lowers yields and thus raises costs, we explored
whether the afﬁnity of Wnt3a for liposomes could be exploited to
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remove contaminants from Wnt3a preparations. Indeed, by
separating the liposomes from a suspension of low-purity Wnt3a
liposomes, we recovered more than 80% of Wnt3a protein while
almost all contaminants were removed, leaving only BSA as a
signiﬁcant presence (Supplementary Fig. 1b and Fig. 5d). These
data show that liposomes facilitate not only the stabilization but
also the production of high-purity Wnt3a protein.
Finally, we explored whether Wnt3a liposomes would support
the derivation of stem cell cultures from other human organs.
Indeed, Wnt3a liposomes supported organoid derivation from
jejunum biopsies (Fig. 6a, Table 1 and Supplementary Fig. 2a,b),
unlike puriﬁed Wnt3a protein and, interestingly, unlike Wnt3a-
conditioned medium (Table 1 and Supplementary Fig. 2a). This
underscores the inconsistent nature of the Wnt3a-conditioned
medium, which was prepared using duodenum-screened serum,
and highlights an additional beneﬁt of Wnt3a liposomes as a
more universally applicable reagent. Jejunum organoids were
maintained for more than 3 months and displayed robust
expansion in the presence of Wnt3a liposomes (Supplementary
Fig. 2b). Furthermore, Wnt3a liposomes supported the derivation
of human liver organoids26 from both three out of four healthy
donors and from three cases with end-stage liver disease (Fig. 6b
and Table 2). Wnt liposomes hold therefore promise for
modelling liver diseases and may have wider applicability.
Discussion
Our study shows that the main technical obstacles with using
Wnt protein for serum-free stem cell cultures are its instability
and its detergent-associated stem cell toxicity. The prolonged
activity of lipid-stabilized Wnt3a and the absence of CHAPS
advance an approach to establish deﬁned long-term cultures of
organoids from human organ stem cells. This removes an
obstacle for the use of these cells in clinical scenarios, and lipid-
stabilized Wnt3a holds therefore considerable translational
potential. Moreover, the lipid stabilization is compatible with
high concentrations of Wnt3a protein and offers advantages for
all tissue culture uses of Wnt3a protein. This is demonstrated by
the considerably improved performance of Wnt3a liposomes in
embryonic stem cell culture.
Several approaches have been used to increase the stability and
activity of Wnt3a in serum-free conditions. In one of the ﬁrst
attempts, serum was fractionated and heparan sulfate proteogly-
cans (HSPGs) identiﬁed as Wnt-stabilizing components11. Due to
their high cost, puriﬁed HSPGs are not currently economically
viable in cell culture applications. Moreover, the basement
membrane extract in which the organ stem cells are cultured is
already rich in HSPGs27. Recently, the serum glycoprotein afamin
was identiﬁed as another serum component able to stabilize
Wnt3a22. Recombinant afamin did, however, not prolong the
activity of puriﬁed Wnt3a in our hands. Since its stabilizing
ability was demonstrated in a coexpression setting22, this suggests
that it depends on the molecules interacting during their
biosynthesis or downstream cellular processing. Moreover, this
suggests that yet other serum components must be able to
stabilize Wnt3a on its dilution in serum-containing medium. This
is also indicated by our ﬁnding that serum-derived contaminants
substantially contribute to Wnt stability, given the inverse
correlation that we observed between Wnt3a purity and stability.
Our work adds several other tools to the Wnt instrumenta-
rium: Lipid-coated PLGA NPs can be stored for years28, and we
show that such particles are as effective as liposomes in
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prolonging the activity of Wnt3a. Alternatively, for systems that
require the elimination of CHAPS, we show that freeze-dried
Wnt3a liposomes retain their activity on reconstitution. Finally,
liposomes efﬁciently recover Wnt3a protein from crude prepara-
tions while leaving behind most contaminants, which may be
applied to improve the economics of Wnt protein puriﬁcation.
Together, these technologies facilitate distribution of and access
to stabilized Wnt ligands.
Methods
Culture of human intestinal and liver organoids. Intestinal biopsies were
obtained from patients with informed consent from Wilhelmina Children’s
Hospital, Utrecht and Erasmus Medical Center, Rotterdam. The biopsies were
included on availability and none were excluded. The use of donor materials for
research purposes was approved by the Medisch Ethische Toetsings Commissies
(Medical Ethics Committees) of Utrecht Medical Center and of Erasmus Medical
Center, and informed consent was obtained from all subjects. Intestinal samples
were collected, washed with cold PBS until the supernatant was clear and tissue
fragments incubated with 2mM EDTA in cold chelation buffer (5.6mM Na2HPO4,
8.0mM KH2PO4, 96.2mM NaCl, 1.6mM KCl, 43.4mM sucrose, 54.9mM
D-sorbitol, 0.5mM DL-dithiothreitol) for 30min on ice. Tissue fragments were
vigorously resuspended in cold chelation buffer using a 10ml pipette to isolate
intestinal crypts. After settling of tissue fragments, the supernatant containing
crypts was collected, the crypts pelleted, washed with cold chelation buffer and
centrifuged at 150g to remove single cells. Crypts were then mixed with Cultrex
Basement Membrane Extract, Type 2 (BME; Amsbio) on ice and 50 ml drops plated
in a 24-well plate (1,000 crypts per fragments per 50 ml of BME per well). The plate
was incubated for 10min at 37 C to allow the BME to solidify, after which 500 ml
of warm complete culture medium was overlaid. Outgrowing crypts of human
duodenum and jejunum were typically refreshed every other day.
Complete culture medium consisted of basal culture medium (Advanced
DMEM/F12 supplemented with 100Uml 1 penicillin and 100 mgml 1
streptomycin, 10mM HEPES and glutamax (all from Invitrogen)) supplemented
with 1 B27 (Invitrogen), 1.25mM N-acetyl cysteine (Sigma), 10mM
nicotinamide, 500 nM A83-01 (Tocris), 10 mM SB202190 (Sigma), 50 ngml 1
epidermal growth factor (Invitrogen), 1 mgml 1 Rspo1 (Nuvelo) or 20%
Rspo1-conditioned medium and 100 ngml 1 Noggin (Peprotech) or 10%
Noggin-conditioned medium, and 400–800 ngml 1 puriﬁed or liposomal
Wnt3a or 50% Wnt3a-conditioned medium.
Rspo1- and Noggin-conditioned media were produced by conditioning basal
culture medium for 1 week using HEK293 cells stably transfected with HA-mouse-
Rpso1-Fc (gift from Calvin Kuo, Stanford University) or mouse Noggin-Fc
expression vector29, respectively. Wnt3a-conditioned medium was produced by
conditioning medium containing 10% screened fetal bovine serum (Sigma) for 1
week using Wnt3a-expressing L cells (gift from Roel Nusse, Stanford University).
All cells lines were tested for mycoplasma contamination every 2–3 months.
Human or mouse Wnt3a protein was purchased from R&D Systems, or produced
in Drosophila S2 cells grown in suspension culture (gift from Roel Nusse, Stanford
University) and puriﬁed using Blue Sepharose afﬁnity and gel ﬁltration
chromatography. For this, the S2 cells were expanded in Schneider’s Drosophila
medium (Lonza) containing 10% fetal bovine serum and antibiotics, and media
were collected when cell expansion reached a plateau. Up to 12 L of conditioned
medium was 0.45 mm ﬁltered, adjusted to 1% Triton X-100 and applied to an FPLC
column containing 200ml Blue Sepharose 6 Fast Flow (GE Healthcare; 17094801).
After washing with four volumes of washing buffer (150mM KCl, 20mM
Tris-HCl, 1% CHAPS, pH 7.5), bound proteins were eluted with elution buffer
(1.5M KCl, 20mM Tris-HCl, 1% CHAPS, pH 7.5). After analysis on a Coomassie
gel, Wnt3a-containing fractions were selected, combined and concentrated to
10ml using Pierce Concentrators 20K MWCO (Thermo Scientiﬁc; 89887A). The
combined fractions were fractionated on a HiLoad 26/60 Superdex 200 gel ﬁltration
column (GE Healthcare) in PBS, 0.5M NaCl, 1% CHAPS, pH 7.3. Fractions
were analysed for purity and Wnt activity by Coomassie gel and Wnt activity assay
(see below), and selected fractions were combined for use.
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Figure 5 | Liposome-mediated Wnt3a puriﬁcation. (a) SDS–polyacrylamide gel electrophoresis (SDS–PAGE) analysis of batches of Wnt3a protein of low
(1) and high purity (2) detected by Oriole stain. (b) Quantiﬁcation of Wnt activity retained after incubation of 250ngml 1 Wnt3a protein from the batches
of (a) in the indicated conditions in serum-free medium for the indicated amounts of time at 37 C (n¼ 3, mean±s.e.m.). (c) Expansion of single human
duodenum organoid cells (passage 9) able to form new organoids in the presence of 800ngml 1 high-purity Wnt3a protein as indicated (n¼ 3,
mean±s.e.m.). (d) SDS–PAGE analysis of low-purity Wnt3a liposome suspension (1) and the same liposomes after separation from the suspension (2),
detected by Oriole stain. L, molecular weight ladder (kDa).
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Human liver biopsies (0.5–1 cm3) were obtained from multi-organ donors and
explant livers during liver transplantations performed at the Erasmus MC,
Rotterdam. The biopsies were included on availability and none were excluded.
The use of both donor and recipient materials for research purposes was approved
by the Medisch Ethische Toetsings Commissie (Medical Ethics Committee) of
Erasmus Medical Center, and informed consent was obtained from all subjects. To
isolate liver cells from the biopsies, the minced tissue was washed with DMEM/1%
FCS and digested with collagenase D (2.5mgml 1, Roche) and DNase I
(0.1mgml 1, Sigma) in Earle’s balanced salt solution (Thermoscientiﬁc) for
30min at 37 C. After the addition of cold DMEM/1% FCS, the suspension was
ﬁltered through a 70mm strainer and pelleted for 5min at 300g. The material
retained in the strainer was further digested for 10min with Accutase (Gibco) at
37 C and strained again. The strained fractions were combined, washed with cold
Advanced DMEM/F12 and pelleted at 300g for 5min. The cell pellet was mixed
Donor 1 Donor 2
P7 P9 P6 P8
P1 P1 P3P4
i ii iii
a
b
Figure 6 | Wnt3a liposomes support serum-free establishment of human jejunum and liver organoids. (a) Human jejunum organoids derived in the
presence of Wnt3a liposomes (800ng Wnt3a per ml) in serum-free medium. (b) Human liver organoids derived in the presence of Wnt3a liposomes
(800ng Wnt3a per ml) in serum-free medium from patient biopsies with (i) hepatitis C combined with hepatocellular carcinoma, (ii) a-1 antitrypsin
deﬁciency and (iii) Wilson’s disease. Scale bars, (a) 100mm and (b) 50mm. P, passage.
Table 1 | Wnt3a liposomes support serum-free derivation of human small intestinal organoids.
Wnt3a reagent Concentration Donor and tissue type
Duodenum Donor 1 Jejunum Donor 2 Jejunum
Wnt3a CM 50%  — —
Puriﬁed Wnt3a 200 ngml 1 ND — ND
Puriﬁed Wnt3a 400ngml 1 — — —
Puriﬁed Wnt3a 800ngml 1 ND — —
Puriﬁed Wnt3a 1,000 ngml 1 ND ND —
Vehicle liposomes 0 ngml 1 Wnt3a — — —
Wnt3a liposomes 200 ngml 1 ND — ND
Wnt3a liposomes 400ngml 1  — 
Wnt3a liposomes 800ngml 1   
Wnt3a liposomes 1,000 ngml 1 ND ND 
CM, conditioned medium; , successful organoid establishment; ND, not determined.
Derivations of organoids from human duodenum and jejunum biopsies in the presence of the indicated Wnt3a reagents.
Table 2 | Wnt3a liposomes support serum-free derivation of human liver organoids.
Human liver tissue source Underlying disease Number of donors Successful organoid derivations
Multi-organ donors Cardiac arrest and/or brain death 4 3
End-stage liver disease patients HCV combined with HCC 1 1
a-1 Antitrypsin deﬁciency 1 1
Wilson’s disease 1 1
HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
Derivations of organoids from biopsies of human liver obtained from multi-organ donors and end-stage liver disease patients in the presence of Wnt3a liposomes (800 ng Wnt3a per ml).
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with Matrigel (BD Biosciences) and 10,000 cells were seeded per well in a 48-well
plate. The cell–Matrigel mix was incubated for 30min at 37 C, after which 250 ml
culture medium was added. Culture media consisted of Advanced DMEM/F12
(Invitrogen) supplemented with N2 and B27 without retinoic acid (Gibco),
1.25mM N-acetyl cysteine (Sigma), 10 nM gastrin (Sigma), 50 ngml 1 epidermal
growth factor (Peprotech), 10% RSPO1 conditioned medium, 100 ngml 1 FGF10
(Peprotech), 25 ngml 1 HGF, 10mM nicotinamide (Sigma), 5 mM A83.01
(Tocris) and 10mM FSK (Tocris). For the establishment of the culture, the ﬁrst 3
days after isolation the medium was supplemented with 25 ngml 1 Noggin
(Peprotech), Wnt3a liposomes (800 ngml 1) and 10 mM Y27632 (Sigma).
Intestinal organoid proliferation assay. To quantify proliferation rate, organoid
cultures were dissociated into single cells by incubating with TrypLE reagent
(Invitrogen) at 37 C for 5–10min. Viable cells were counted and 1,500–3,500
viable single cells were seeded with 100ml of complete culture medium supple-
mented with either Wnt CM or liposomal Wnt3a into U-bottom 96-well plates in
ﬁve replicates for each condition. The cultures were incubated for 1, 3, 6 and 8
days. The culture medium was then removed from the wells and 50 ml of basal
medium was added. Next, an equal volume of CellTiter-Glo Reagent (Promega)
was added directly to the wells. Plates were incubated at room temperature for
10min on a shaker in the dark. The samples were transferred into opaque-walled
white 96-well plates for luminescence measurements done on a Centro XS LB 960
Multiplate Luminometer (Berthold Technologies). Values were normalized and
expressed as the mean of three wells±s.e.m. relative to the starting cell numbers.
Clonal organoid formation assay. For quantiﬁcation of organoid-forming
cells, organoids cultured were dissociated into single cells by TrypLE express
(Life Technologies), and 2,000 single cells mixed with BME (50ml per well) were
seeded into 24-well plates in triplicates. The single cells were cultured in complete
culture medium (as described above) containing the indicated concentration of
puriﬁed or liposomal Wnt3a or CHIR99021 (Tocris; 4423-10). Media were
changed every other day. After 7–10 days, the number of organoids formed was
counted. The organoids were again dissociated into single cells and passaged at a
dilution that would result in 2,000 single cells per well again. The cumulative
number of organoids formed at this passage was determined after correcting for the
dilution factor used during passaging. Results were plotted as the mean of three
wells±s.e.m.
Preparation and characterization of liposomal Wnt3a. For preparation of
liposomes, DMPC, DMPG (both from Lipoid AG) and cholesterol (Sigma) were
mixed at molar ratios indicated in brackets, and dissolved in a 9/1 (v/v) mixture of
chloroform/methanol. The solvent was then evaporated under vacuum on a
rotavapor to generate a lipid ﬁlm. The residual organic solvent was removed by a
nitrogen ﬂush. Following hydration of the lipid ﬁlm in HEPES-buffered saline
(HBS: 10mM HEPES buffer (pH 7.2), 0.8% NaCl) or PBS, the lipid suspension was
extruded 10 times each through 200 and 100 nm pore size polycarbonate ﬁlters
(Northern Lipids) using nitrogen pressure and a Lipex high pressure extruder
(Northern Lipids). The mean particle size and size distribution (polydispersity
index) of the liposomes were determined with dynamic light scattering using a
Malvern Zetasizer. The liposomes were stored under argon at 4 C until use.
Puriﬁed Wnt3a protein (see above) was mixed with liposomes at a 1:7.5 ratio for
ﬁnal concentrations of 7–15mgml 1 Wnt3a and 15mM phospholipid, unless
indicated otherwise. The Wnt3a liposomes were incubated for 1 h at 4 C, followed
by dialysis in HBS/PBS at 4 C using a 10 kDa molecular weight cutoff membrane.
To obtain higher Wnt3a concentrations (15–25 mgml 1) in the liposomes,
multiple rounds of incubation with puriﬁed Wnt3a and subsequent dialysis were
performed. Phospholipid concentrations were determined by a colorimetric
phosphate assay30. First, 2–6ml of liposome dispersions were dried in glass test
tubes for 30min at 180 C. Phospholipids were then degraded by the addition of
0.3ml 70% perchloric acid, followed by a 45min incubation at 180 C until the
samples became colourless. Evaporation of the perchloric acid was prevented by
placing porcelain marbles on top of the tubes. Once the test tubes were cooled
down to room temperature, 1ml of water was added, followed by 0.5ml of 1.2%
hexa-ammoniummolybdate solution. Samples were mixed by vortexing, 0.5ml of
a freshly prepared solution of 5% (w/v) ascorbic acid was added and vortexed
again. Samples were then placed in boiling water for 5min and subsequently
allowed to cool down to room temperature. Samples were transferred to disposable
cuvettes and absorbance was measured at 797 nm against a calibration curve
prepared with known amounts of sodium phosphate (NaH2PO4).
To separate liposome-associated from -unincorporated Wnt3a proteins, the
Wnt3a liposome suspensions were centrifuged for 30min at 100,000g at 4 C. The
pellet was resuspended in PBS and together with the supernatant analysed by
western blotting. Wnt3a protein was detected by a rabbit monoclonal anti-Wnt3a
antibody (Cell Signaling Technology; 2721) using a goat anti-rabbit IRDye 800CW
secondary antibody (Li-Cor) and imaged on an Odyssey Infrared Imaging System
(Li-Cor). For each band, background-subtracted quantiﬁcation numbers, the
so-called integrated intensities, were generated with the analysis software provided.
Ratios of integrated intensities were calculated and results were plotted as the
percentage of either free or liposome-associated Wnt3a relative to the total amount.
Residual CHAPS content of Wnt3a reagents was determined by means of HPLC
(Alliance Waters 2695, Waters, USA), using reversed-phase chromatography and
UV detection (Dual l Absorbance detector, Waters, USA) at a wavelength of
210 nm. The column used was a LiChrospher 100, RP-18 (5 mM). As a mobile
phase, 4% acetonitrile, 95.9% water and 0.1% perchloric acid was used at a ﬂow rate
of 1.0mlmin 1.
Lyophilization of liposomal Wnt3a. Liposomes (DMPC/DMPG/cholesterol
10:1:10) were prepared as described above, except that 10% sucrose in 10mM
HEPES (pH 7.4) was used instead of HBS for hydration of the lipid ﬁlm. Wnt3a
and vehicle liposomes were prepared as described above and dialysed in 10%
sucrose in 10mM HEPES (pH 7.4) at 4 C. The liposomes were then freeze-dried in
200 ml aliquots in 3.5ml ﬂat bottom vials in a Lyovac GT4 freeze-dryer (Leybold-
Heraeus, Cologne, Germany). The vials were placed on the freeze-dryer plate at a
temperature of  40 C. First, the plate temperature was maintained at  40 C at
a chamber pressure of 10–13 Pa for 24 h. Then, the plate temperature was increased
to 0 C and the chamber pressure was adjusted to 0.9–1 Pa. Twenty-four hours
later, the chamber was ﬁlled with nitrogen gas, the vials closed and sealed with
rubber and aluminium caps and stored at  20 C until use. One hour before use,
freeze-dried liposomes were allowed to come to room temperature and were
reconstituted by adding 200 ml distilled water, followed by 1min of rigorous
vortexing. Particle size measurements were carried out using a Zetasizer (Malvern).
Preparation of Wnt3a-coated PLGA NPs. For preparation of lipid-coated PLGA
NPs, we ﬁrst prepared PLGA NPs using an oil/water emulsion and solvent
evaporation–extraction method. In brief, for each preparation 100mg of PLGA
(Resomer RG 502 H, lactide:glycolide molar ratio 48:52 to 52:48; Sigma-Aldrich) in
3ml of dichloromethane (DCM; Sigma-Aldrich) was added drop wise to 25ml of
aqueous 2% (w/v) polyvinyl alcohol (Sigma-Aldrich) in distilled water, and
emulsiﬁed for 90 s using a Branson sonoﬁer 250 sonicator. Next, a ﬁlm of DMPC
was prepared by dissolving 10mg of DMPC in DCM, followed by evaporation of
the DCM by a stream of nitrogen gas. Subsequently, the PLGA emulsion was
rapidly added to the vial containing the lipids and the solution was homogenized
for 30 s using a sonicator. Following overnight evaporation of the solvent at 4 C,
the lipid-coated PLGA NPs were collected by centrifugation at 10,000g for 10min,
washed three times with distilled water and lyophilized. The Z-average size and
polydispersity index of the lipid-coated PLGA NPs were measured by dynamic
light scattering using a Nano ZS Zetasizer (Malvern). The corresponding particle
diameter was calculated assuming that the particles were spherical with a value of
178±4 nm, while the polydispersity index with a value of 0.09±0.01. To associate
PLGA NPs with Wnt3a, the NPs were resuspended in PBS at a concentration of
10mgml 1, incubated for 1 h with Wnt3a proteins at a 1:7.5 ratio for a ﬁnal
Wnt3a concentration of 7–10 mgml 1, followed by dialysis against PBS to remove
CHAPS.
Wnt activity assays. Mouse LSL cells31 (gift from Roel Nusse, Stanford
University), expressing luciferase in response to TCF promoter binding, were
cultured at 37 C and 5% CO2 in DMEM containing 10% FCS, 100Uml 1
penicillin and 100mgml 1 streptomycin. The cells were tested for mycoplasma
contamination every 2–3 months. For the activity assays, 25,000 LSL cells were
plated in each well of a 96-well plate 24 h in advance. Wnt3a reagents and human
recombinant afamin (Sino Biological; 13231-H08H-50) as indicated were
separately incubated in serum-free culture medium for various periods of time at
37 C in 96-well plates. On completion of incubation intervals, media containing
Wnt3a reagents were added to LSL cells and incubated overnight, followed by cell
lysis and luciferase activity assay using Promega luciferase assay reagent and a
Glomax multiplate reader.
Embryonic stem cell culture and clonal self-renewal assays. R1 embryonic
stem cells (obtained from Stanford Transgenic Facility) and R1-7xTcf-eGFP
ESCs16 were cultured on gelatine and FCS-coated plates in N2B27 medium,
composed of one volume of DMEM/F12 and one volume neurobasal medium
supplemented with 0.5% N2 supplement, 1% B27 supplement, 0.033% BSA 7.5%
solution, 50 b-mercaptoethanol, 2mM glutamax, 100Uml 1 penicillin and
100 mgml 1 streptomycin (all from Invitrogen). Puriﬁed Wnt3a of 250 ngml 1
was added to the ESC medium, and the medium was refreshed every day. ESCs
were passaged at a ratio of 1:10 every 3 days as a single-cell suspension using 0.25%
trypsin-EDTA and trypsin was quenched using soybean trypsin inhibitor (Sigma).
The cells were tested for mycoplasma contamination every 2–3 months.
For assessment of Wnt-responsive reporter activation over several days,
50,000 R1-7xTcf-eGFP ESCs were plated on gelatine and FCS-coated 6-well
plates in quadruplicates in the presence of 2mM IWP2 (Merck; 681671). The same
concentration of Wnt3a (250 ngml 1) either in the form of puriﬁed or liposomal
Wnt3a as well as control lipid-vesicles containing the same amount of liposomes
were added to the wells at day 0 only and the cells were no longer refreshed.
The ESCs were imaged every day with an Olympus IX-70 inverted ﬂuorescent
microscope. Following imaging, one well of ESCs from each condition was
analysed for GFP expression by ﬂow cytometry (Fortessa, BD biosciences).
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To quantify self-renewal of ESCs, single cells were plated at a clonal density of
200 cells per cm2 in gelatine- and FCS-coated 6-well plates and in 24-well plates in
triplicates. Media containing the indicated supplements were refreshed daily or
each passage, as indicated. Every 3 days, 6-well plates were trypsinized to single
cells, and passaged at a dilution that would result in clonal density again.
Concurrently, the 24-well plates were stained for alkaline phosphatase by SCR004
Kit (Millipore) according to the manufacturer’s instructions. Stained plates were
rinsed with water, dried and counted manually under microscope. The cumulative
number of colonies was determined by multiplying the colony counts by the
dilution factor used for passaging. Results were plotted as the mean of three
wells±s.e.m.
Quantitative RT–PCR analysis. Organoid cultures were collected in RLT buffer
from RNeasy Mini Kit (Qiagen) and RNA isolated according to the manufacturer’s
instructions. Reverse transcription was performed using Superscript II (Invitrogen).
cDNA was ampliﬁed in triplicate with LightCycler 480 SYBR Green Master mix
(Roche) on a Roche Lightcycler 480. Relative quantiﬁcation was achieved by
normalizing mean values to the GAPDH gene and reported±s.e.m. The following
primers were used: LGR5 forward, 50-AGGTCTGGTGTGTTGCTGAG-30 and
LGR5 reverse, 50-GTGAAGACGCTGAGGTTGGA-30 ; TROY forward, 50-AACT
GTGTTCCCTGCAACCA-30 and TROY reverse, 50-
GTCCTCCTTGAACCTGTGCA-30 .
Histology and imaging. For immunochemistry staining, organoids were ﬁxed
with 4% paraformaldehyde for 1 h at room temperature, embedded in parafﬁn,
sectioned at 5 mm and sections processed for periodic acid-Schiff and alkaline
phosphatase staining or immunohistochemical staining. Antibodies used were as
follows: mouse anti-Ki67 (1:250, Monosan MONX10283), anti-chromogranin
A (1:100; Santa Cruz; sc-1488) and anti-EphB2 (R&D systems; AF647). For whole-
mount immunostaining, samples were ﬁxed by the addition of equal amounts of
4% prewarmed paraformaldehyde to the wells and incubated for 2 h at 37 C. The
wells were washed three times with prewarmed PBS. Next, Matrigel was dissolved
by the addition of cold Cell Recovery Solution (BD Biosciences), followed by a
30min incubation at 4 C. The recovered organoids were cytospun for 2min at
500 r.p.m. on glass slides and antigens retrieved by boiling the samples in sodium
citrate buffer (10mM, pH 6.0) for 10min. The samples were then washed three
times for 10min with PBS containing 0.2% Tween-20 (PBST), permeabilized with
0.1% Triton in PBS for 10min at room temperature and blocked with 5% non-fat
dry milk (Sigma) and 0.1% Triton in PBS for 30min. Incubation with primary or
secondary antibodies diluted in blocking solution was done overnight at 4 C or
1–2 h at room temperature, respectively, followed by three washes in PBST for
10min. The primary antibodies used were as follows: anti-Mucin2 (1:500, cat. no.:
SC-15334; Santa Cruz), anti-lysozyme (1:1,000; cat. no.: A0099; Dako), anti-Villin
(1:100; cat. no.: 610359; BD Biosciences) and anti-chromogranin A (1:250; cat. no.:
NB120-15160; Novus Biological). The secondary antibodies were Alexa-Fluor-488
and Alexa-Fluor-594. Nuclei were stained with DAPI (Molecular Probes) for 5min
at room temperature. Immunoﬂuorescence confocal images were acquired using
a Zeiss LSM 700 inverted laser-scanning confocal microscope equipped with an
external argon laser.
Statistical analysis. All luciferase reporter, colony counting and RT–PCR assays
were performed as three technical replicates. Standard errors of the means were
calculated assuming normal distribution of the data.
Data availability. All relevant data generated or analysed during this study are
included in this published article and its Supplementary Information Files or from
the corresponding author on reasonable request.
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